Interview with Eli Lilly CEO: Artificial intelligence is set to transform the pharmaceutical and biotech sector
David Ricks, CEO of Eli Lilly. Eli Lilly Biotech and pharmaceutical companies are considering how AI could improve their businesses. The Eli Lilly CEO said he expects AI to massively change workplace productivity. The pharmaceutical giant is investing in AI, machine learning and automation. This story is part of “What’s Next?”, a series in which … Read more